Get the Stockscreener App
28.51
1.75%
0.49
After Hours:
28.51
Immunovant Inc stock is traded at $28.51, with a volume of 654.77K.
It is up +1.75% in the last 24 hours and down -7.73% over the past month.
Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes batoclimab and IMVT-1402 targets the neonatal Fc receptor (FcRn).
See More
Previous Close:
$28.02
Open:
$27.65
24h Volume:
654.77K
Relative Volume:
0.66
Market Cap:
$4.17B
Revenue:
-
Net Income/Loss:
$-243.45M
P/E Ratio:
-14.77
EPS:
-1.93
Net Cash Flow:
$-210.56M
1W Performance:
+0.60%
1M Performance:
-7.73%
6M Performance:
-11.76%
1Y Performance:
-25.74%
1-Day Range:
$27.61
$28.75
1-Week Range:
$27.61
$29.80
52-Week Range:
$24.67
$45.58
Immunovant Inc Stock (IMVT) Company Profile
Name
Immunovant Inc
Sector
Industry
Phone
917-580-3099
Address
320 WEST 37TH STREET, NEW YORK, NY
Immunovant Inc Stock (IMVT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-15-24 | Initiated | Wolfe Research | Outperform |
| Dec-12-23 | Initiated | Deutsche Bank | Buy |
| Oct-13-23 | Upgrade | UBS | Neutral → Buy |
| Sep-26-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-01-23 | Initiated | BofA Securities | Buy |
| Apr-25-23 | Initiated | Citigroup | Buy |
| Mar-31-23 | Initiated | Piper Sandler | Overweight |
| Mar-30-23 | Initiated | Stifel | Buy |
| Feb-15-23 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-13-23 | Upgrade | Guggenheim | Neutral → Buy |
| Jan-03-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Sep-26-22 | Downgrade | UBS | Buy → Neutral |
| Dec-08-21 | Initiated | Wells Fargo | Equal Weight |
| Aug-03-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Aug-02-21 | Downgrade | Credit Suisse | Neutral → Underperform |
| Jun-01-21 | Downgrade | Guggenheim | Buy → Neutral |
| Jun-01-21 | Downgrade | Stifel | Buy → Hold |
| Oct-28-20 | Initiated | UBS | Buy |
| Oct-12-20 | Initiated | Guggenheim | Buy |
| Oct-08-20 | Initiated | Stifel | Buy |
| Oct-02-20 | Initiated | Credit Suisse | Outperform |
| Aug-26-20 | Reiterated | H.C. Wainwright | Buy |
| Aug-25-20 | Initiated | Raymond James | Outperform |
| Jul-29-20 | Initiated | H.C. Wainwright | Buy |
| Feb-24-20 | Initiated | SVB Leerink | Outperform |
View All
Immunovant Inc Stock (IMVT) Latest News
Immunovant Inc (IMVT) is looking forward to a strong quarter - SETE News
Immunovant (NASDAQ:IMVT) Stock Rating Reaffirmed by HC Wainwright - MarketBeat
Blue Owl Capital Holdings LP Has $2.11 Million Stock Position in Immunovant, Inc. (NASDAQ:IMVT) - MarketBeat
Armistice Capital LLC Has $89.68 Million Position in Immunovant, Inc. (NASDAQ:IMVT) - Defense World
Fred Alger Management LLC Trims Stake in Immunovant, Inc. (NASDAQ:IMVT) - Defense World
Stocks of Immunovant Inc (IMVT) are poised to climb above their peers - SETE News
Immunovant, Inc. (NASDAQ:IMVT) is Armistice Capital LLC's 6th Largest Position - MarketBeat
Insider’s View: Deciphering Immunovant Inc (IMVT)’s Financial Health Through Ratios - The Dwinnex
Immunovant (NASDAQ:IMVT) Trading 2.7% Higher - MarketBeat
Immunovant (NASDAQ:IMVT) Trading Up 2.7% - Defense World
Oppenheimer initates Immunovant Inc (IMVT) stock to an Outperform - Knox Daily
A closer look at Immunovant Inc (IMVT)’s stock price trends - US Post News
Goldman Sachs sustains price target, buy rating on Immunovant shares By Investing.com - Investing.com Canada
Profund Advisors LLC Sells 18,864 Shares of Immunovant, Inc. (NASDAQ:IMVT) - Defense World
Profund Advisors LLC Sells 18,864 Shares of Immunovant, Inc. (NASDAQ:IMVT) - MarketBeat
Farallon Capital Management LLC Takes $317,000 Position in Immunovant, Inc. (NASDAQ:IMVT) - Defense World
Logos Global Management LP Sells 1,200,000 Shares of Immunovant, Inc. (NASDAQ:IMVT) - Defense World
Renaissance Technologies LLC Acquires 48,400 Shares of Immunovant, Inc. (NASDAQ:IMVT) - Defense World
Seven Eight Capital LP Has $279,000 Stock Holdings in Immunovant, Inc. (NASDAQ:IMVT) - Defense World
Renaissance Technologies LLC Acquires 48,400 Shares of Immunovant, Inc. (NASDAQ:IMVT) - MarketBeat
Ankyra Announces Appointment of Dr. Julia Butchko and Ms. Tara Withington to the Board of Directors - StockTitan
Rubric Capital Management LP Purchases Shares of 58,624 Immunovant, Inc. (NASDAQ:IMVT) - MarketBeat
Rubric Capital Management LP Invests $1.55 Million in Immunovant, Inc. (NASDAQ:IMVT) - Defense World
Rhumbline Advisers Has $2.21 Million Holdings in Immunovant, Inc. (NASDAQ:IMVT) - Defense World
Immunovant, Inc. (NASDAQ:IMVT) Shares Sold by E Fund Management Co. Ltd. - Defense World
Trading (IMVT) With Integrated Risk Controls - Stock Traders Daily
Immunovant Inc (IMVT) did well last session? - US Post News
ImmunityBio, Inc. (NASDAQ:IBRX) Shares Purchased by Private Advisor Group LLC - Defense World
Roivant Deals Again, Sending Dermavant to Organon in Sale Worth Up to $1.2B - BioSpace
Quest Partners LLC Grows Position in Immunovant, Inc. (NASDAQ:IMVT) - Defense World
Recent Insider Activity Could Benefit Immunovant Inc (IMVT) - Knox Daily
IBRX Stock on the Rise: A Promising Investment - The InvestChronicle
WINTON GROUP Ltd Buys Shares of 20,675 Immunovant, Inc. (NASDAQ:IMVT) - MarketBeat
IVV And The S&P 500: How Bad Could It Get? (NYSEARCA:IVV) - Seeking Alpha
Headlands Technologies LLC Buys New Stake in Immunovant, Inc. (NASDAQ:IMVT) - Defense World
Immunic (NASDAQ:IMUX) Raised to Strong-Buy at EF Hutton Acquisition Co. I - MarketBeat
A new trading data show Immunovant Inc (IMVT) is showing positive returns. - SETE News
Balance Sheet Dive: Immunovant Inc (IMVT)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
Immunovant, Inc. (NASDAQ:IMVT) Stake Lessened by Los Angeles Capital Management LLC - Defense World
Victory Capital Management Inc. Boosts Holdings in Immunome, Inc. (NASDAQ:IMNM) - Defense World
Victory Capital Management Inc. Cuts Position in Immunovant, Inc. (NASDAQ:IMVT) - Defense World
TD Asset Management Inc Sells 32,242 Shares of Immunovant, Inc. (NASDAQ:IMVT) - MarketBeat
Immunovant, Inc. (NASDAQ:IMVT) Shares Sold by TD Asset Management Inc - Defense World
First Turn Management LLC Buys 182,535 Shares of Immunovant, Inc. (NASDAQ:IMVT) - MarketBeat
FY2026 EPS Estimates for Immunovant, Inc. (NASDAQ:IMVT) Decreased by Analyst - Defense World
Immunovant, Inc. to Post FY2026 Earnings of ($2.82) Per Share, Leerink Partnrs Forecasts (NASDAQ:IMVT) - MarketBeat
Bank of New York Mellon Corp Has $6.61 Million Holdings in Immunovant, Inc. (NASDAQ:IMVT) - MarketBeat
Immunovant, Inc. (NASDAQ:IMVT) Shares Acquired by Bank of New York Mellon Corp - Defense World
What the Options Market Tells Us About Immunovant - Benzinga
A stock that deserves closer examination: Immunovant Inc (IMVT) - US Post News
Financial Metrics Exploration: Understanding Immunovant Inc (IMVT) Through Ratios - The Dwinnex
Immunovant Inc Stock (IMVT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):